HN2001000024A - Composiciones mejoradas inmunomoduladoras y neutralizantes de anticuerpos. - Google Patents

Composiciones mejoradas inmunomoduladoras y neutralizantes de anticuerpos.

Info

Publication number
HN2001000024A
HN2001000024A HN2001000024A HN2001000024A HN2001000024A HN 2001000024 A HN2001000024 A HN 2001000024A HN 2001000024 A HN2001000024 A HN 2001000024A HN 2001000024 A HN2001000024 A HN 2001000024A HN 2001000024 A HN2001000024 A HN 2001000024A
Authority
HN
Honduras
Prior art keywords
antibodies
immunomodulating
neutralizing compositions
neutralizing
compositions
Prior art date
Application number
HN2001000024A
Other languages
English (en)
Inventor
Gary R Davis
Original Assignee
Nostrum Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nostrum Biotechnology Inc filed Critical Nostrum Biotechnology Inc
Publication of HN2001000024A publication Critical patent/HN2001000024A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/12—Immunoglobulins specific features characterized by their source of isolation or production isolated from milk

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION EN EL CAMPO DE LA BIOLOGIA CELULAR, LA PSICOLOGIA Y LA MEDICINA SE RELACIONA CON LAS COMPOSICIONES BIOACTIVAS QUE CONTIENEN UNA COMBINACION DE ANTIGENO Y ANTICUERPOS HETEROLOGOS PARE PRODUCIR UNA COMPOSICION INMUNOMODULADORA PARA EL USO EN EL TRTAMIENTO DE INFECCIONES INMUNOSUPRESORAS.
HN2001000024A 2000-02-14 2001-02-14 Composiciones mejoradas inmunomoduladoras y neutralizantes de anticuerpos. HN2001000024A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18242800P 2000-02-14 2000-02-14

Publications (1)

Publication Number Publication Date
HN2001000024A true HN2001000024A (es) 2001-06-18

Family

ID=22668433

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000024A HN2001000024A (es) 2000-02-14 2001-02-14 Composiciones mejoradas inmunomoduladoras y neutralizantes de anticuerpos.

Country Status (6)

Country Link
US (1) US20020086022A1 (es)
AP (1) AP2001002073A0 (es)
AU (1) AU2001236525A1 (es)
GT (1) GT200100029A (es)
HN (1) HN2001000024A (es)
WO (1) WO2001060156A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002317285B2 (en) * 2001-07-02 2007-05-24 Aimsco Limited Use of polyclonal anti-HIV goat serum as a therapeutic agent
JP2005532261A (ja) * 2002-01-28 2005-10-27 エイムスコ・リミテッド 治療
US20060099224A1 (en) 2002-08-12 2006-05-11 David Kirn Methods and compositions concerning poxviruses and cancer
AU2003287082A1 (en) * 2002-10-11 2004-05-04 Imutex Pharmaceuticals, Inc. Heterologous plasma cocktail for hiv treatment
US20060110405A1 (en) * 2004-08-20 2006-05-25 Buckheit Robert W Jr Plasma or serum fraction for treatment and prevention of viral infections and related conditions
JP2009507853A (ja) 2005-09-07 2009-02-26 ジェンネレックス インコーポレイティッド Ｇｍ−ｃｓｆ発現ポックスウイルスを用いる転移性および／または全身播種性癌の全身処置
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
US20080102073A1 (en) * 2006-10-30 2008-05-01 Wayne Koff Antigen-Antibody Complexes as HIV-1 Vaccines
KR101759888B1 (ko) 2009-09-14 2017-07-20 신라젠(주) 종양 용해 백시니아 바이러스 병용 암 치료요법
CN103429258B (zh) * 2011-01-04 2016-03-09 新罗杰公司 通过施用溶瘤痘苗病毒生成针对肿瘤抗原的抗体和生成肿瘤特异性补体依赖性细胞毒性
KR102151962B1 (ko) 2020-03-24 2020-09-04 안병철 어린 포유동물의 전염성 질병을 예방 또는 치료하기 위한 혈청 조성물의 제조방법, 상기 방법에 의해 제조된 혈청 조성물 및 이의 용도

Also Published As

Publication number Publication date
GT200100029A (es) 2001-10-25
US20020086022A1 (en) 2002-07-04
WO2001060156A1 (en) 2001-08-23
AP2001002073A0 (en) 2001-03-31
WO2001060156A9 (en) 2002-10-31
AU2001236525A1 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
HN2001000027A (es) Derivados de purina
AR022965A1 (es) Vacuna
HN2003000054A (es) Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas.
CR10295A (es) "formulacion de un anticuerpo monoclonal humano anti-igf-1r"
HN2001000024A (es) Composiciones mejoradas inmunomoduladoras y neutralizantes de anticuerpos.
BR0309492A (pt) Uso de pelo menos um álcool ramificado alcoxilado
ES2181873T3 (es) Fracciones de polifenoles del te, uso de las mismas y formulaciones que las contienen.
UY28184A1 (es) Formulaciones de inmunoglobulina y metodo de preparacion de la misma.
GT200800132A (es) Anticuerpos anti-il-23 humanos, composiciones, metodos y usos
BR0116470A (pt) éteres de imidazoquinolina substituìdos com uréia
CY1107789T1 (el) Ανθελμινθικαι συνθεσεις περιεχουσαι συνδυασμους αβερμεκτινων ή μιλβεμυκινων μετα δις-αρυλο ενωσεων
CO5180587A1 (es) Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes
ATE314084T1 (de) Kahalalid f formulierung
AR114627A1 (es) Composición inmunogénica
CY1105343T1 (el) Σταφυλοκοκκικη πρωτεϊνη αναστολης του χημειοτακτισμου (chips) και η χρηση αυτης
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
BR0101691B1 (pt) composições de pelìcula de poliolefina com propriedades de antiembaçamento permanentes e uso das referidas composições.
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido
BR0210632A (pt) Tratamento de doença parasìtica
SV2001000253A (es) Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
GT199600072A (es) Formas zwitterionicas de trovafloxacina.
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης